logo-large
  • Browse Categories

Publications by authors named "Deborah L Higgins"

Claim this Profile
T
The inability of tegaserod to affect platelet aggregation and coronary artery tone at supratherapeutic concentrations.
Deborah L Higgins, Mike P Ero, Michelle Loeb, Kathryn Kersey, Alan Hopkins

Naunyn Schmiedebergs Arch Pharmacol· January 2012


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.
Deborah L Higgins, Ray Chang, Dmitri V Debabov, Joey Leung, Terry Wu

Antimicrob Agents Chemother· March 2005


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of TD-6424 against Staphylococcus aureus.
John L Pace, Kevin Krause, Deborah Johnston, Dmitri Debabov, Terry Wu, Deborah L Higgins

Antimicrob Agents Chemother· November 2003


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
John H Griffin, Martin S Linsell, Matthew B Nodwell, QiQi Chen, John L Pace, Deborah L Higgins

J Am Chem Soc· May 2003


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: